Can initial mercaptopurine records predict subsequent neutrophil counts?
Public dosing and ANC records test baseline updating against simple forecasts, without establishing dose-optimization benefit.
Daiki Kumakura
I am a mathematical biologist and a bioinformatics researcher in the pharmaceutical industry. I received my Ph.D. in Life Science from Hokkaido University in March 2025.
I study biological dynamics using mathematical models and data analysis, with an interest in pharmacometrics and systems biology.
ORCIDGoogle ScholarLinkedInGitHub
Recent writing
How much power did the second dose arm cost? Reading the FURVENT topline results
An event-count and power audit of FURVENT separates the cost of a third dose arm from claims about why the trial failed.
How should single-cell metabolic state inference be validated?
Metabolite abundance, flux and metabolic capacity require different validation when interpreting single-cell RNA-based estimates.